Everence Capital Management Inc. trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5 ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirty-one ratings firms that are covering the firm, ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Clover Flex Sihuan Pharmaceutical's exclusive agent for botulinum toxin Letibao is approved for marketing by NMPA Vertex's Kalydeco for cystic fibrosis is close to approval in the EU Two imported new ...

INR:6560. blackjack real Bayer acquires AskBio for $4 billion to expand cell and gene therapy pipeline Vertex's Kalydeco for cystic fibrosis is close to approval i ...

ludo king hack app PARP inhibitor olaparib achieves primary endpoint in phase 3 clinical trial for prostate cancer Vertex's cystic fibrosis combination therapy receives priority review and is expected ...

INR:8074. france vs austria betting tips Science: There is scientific evidence that staying up late makes you stupid!

The top 10 pharmaceutical stocks are released! Hengrui Medicine aims to hit a market value of 370 billion yuan ASH | BTK inhibitor development trends: Eli Lilly, BeiGene, and AZ announce clinical resu ...

How does Hengrui do it? Xavier Biopharma's new NASH drug approved for clinical study Cystic fibrosis giant Vertex: triple combination therapy sales reached nearly $4 billion in one year on the market!

Nature: Large-scale screening discovered 21 existing anti-new coronavirus drugs! Sanofi expands collaboration with US$2.3 billion to develop mRNA vaccines for infectious diseases! Vertex's Kalydeco fo ...